お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989717

多血小板血漿の市場動向・市場シェア・市場規模の予測 (2021-2028年):タイプ・用途 (整形外科・スポーツ医学・美容整形)・エンドユーザー (病院・診療所)・地域別

Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type, By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 147 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
多血小板血漿の市場動向・市場シェア・市場規模の予測 (2021-2028年):タイプ・用途 (整形外科・スポーツ医学・美容整形)・エンドユーザー (病院・診療所)・地域別
出版日: 2021年02月09日
発行: Grand View Research, Inc.
ページ情報: 英文 147 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の多血小板血漿 (PRP) の市場規模は予測期間中12.0%のCAGRで推移し、2028年には12億米ドルの規模に成長すると予測されています。Medicare加入者によるPRP利用の増加、技術的進歩などの要因が同市場の成長を推進しています。

当レポートでは、世界の多血小板血漿 (PRP) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の分類
  • 親市場
  • 市場力学
  • 普及・成長の見通しマッピング
  • COVID-19:影響分析

第4章 事業環境の分析

  • SWOT分析
  • ポーターのファイブフォース分析

第5章 市場予測・動向分析:タイプ別

  • ピュアPRP
  • 高白血球PRP
  • その他

第6章 市場予測・動向分析:用途別

  • 整形外科
  • スポーツ医学
  • 美容整形
  • 皮膚科
  • 眼科手術
  • 脳神経外科
  • 一般外科
  • その他

第7章 市場予測・動向分析:エンドユーザー別

  • 病院
  • クリニック
  • その他

第8章 市場予測・動向分析:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • 戦略的枠組み
  • 参入事業者の分類
  • 企業プロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Growth factors involved in stages of wound healing
  • Table 3 Growth factors involved in wound healing with their origin
  • Table 4 Use of PRP in wound management
  • Table 5 Randomized controlled trials: PRP-based wound healing
  • Table 6 Some of the prominent manufacturers operating in pure PRP market
  • Table 7 Miscellaneous clinical applications for PRP
  • Table 8 Studies that have been approved by CMS for payment coverage with respect to PRP-based ulcer healing
  • Table 9 Comparative analysis of PRP efficacy on chronic ulcers, based on age group and ulcer type
  • Table 10 Some of the hospitals offering PRP treatment for different applications
  • Table 11 Some of the hospitals offering PRP treatment for different applications
  • Table 12 North America Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 13 North America Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 14 North America Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 15 North America Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 16 North America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 17 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 18 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 19 U.S. Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 20 U.S. Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 21 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 22 Canada Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 23 Canada Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 24 Canada Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 25 Canada Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 26 Canada Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 27 Europe Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 28 Europe Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 29 Europe Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 30 Europe Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 31 Europe Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 32 Germany Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 33 Germany Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 34 Germany Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 35 Germany Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 36 Germany Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 37 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 38 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 39 U.K. Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 40 U.K. Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 41 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 42 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 43 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 44 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 45 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 46 North America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 47 Some of the PRP service providers in Japan
  • Table 48 Japan Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 49 Japan Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 50 Japan Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 51 Japan Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 52 Japan Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 53 China Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 54 China Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 55 China Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 56 China Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 57 China Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 58 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 59 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 60 Latin America Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 61 Latin America Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 62 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 63 Some of the hospitals & dental clinics for platelet rich plasma therapy in Brazil
  • Table 64 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 65 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 66 Brazil Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 67 Brazil Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 68 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 69 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 70 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 71 Mexico Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 72 Mexico Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 73 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 74 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 75 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 76 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 77 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 78 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)
  • Table 79 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 80 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 81 South Africa Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2017 - 2028 (USD Million)
  • Table 82 South Africa Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2017 - 2028 (USD Million)
  • Table 83 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 PRP segment revenue modeling
  • Fig. 5 Sports medicine market segment revenue modeling
  • Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
  • Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
  • Fig. 8 Market research approaches
  • Fig. 9 Value chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Platelet rich plasma (PRP) market snapshot, 2020 (USD Million)
  • Fig. 13 Platelet rich plasma (PRP) market segmentation
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
  • Fig. 16 Incidence of arthritis in U.S., by age
  • Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
  • Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
  • Fig. 19 Common cosmetic surgical procedures in 2019
  • Fig. 20 Cosmetic plastic demographic data in 2019
  • Fig. 21 Common minimal invasive procedures in 2019, U.S.
  • Fig. 22 Number of customers for cosmetic surgery in China (Million)
  • Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
  • Fig. 24 Market restraint relevance analysis (Current & future impact)
  • Fig. 25 Market opportunity relevance analysis (Current & future impact)
  • Fig. 26 Penetration and growth prospect mapping, by Application, 2020
  • Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
  • Fig. 28 Platelet rich plasma (PRP) market Porter's five forces analysis
  • Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
  • Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
  • Fig. 31 Pure PRP market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 32 Leukocyte rich PRP market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 33 PRP market estimates and forecast for others, 2017 - 2028 (USD Million)
  • Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
  • Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
  • Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2017 - 2028
  • Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2017 - 2028
  • Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2017 - 2028
  • Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2017 - 2028
  • Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
  • Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
  • Fig. 42 Categorization of studies based on types of ulcers
  • Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2017 - 2028
  • Fig. 44 Meta-analysis of lower extremity venous ulcers
  • Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2017 - 2028
  • Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2017 - 2028
  • Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2017 - 2028
  • Fig. 48 Results obtained for individuals treated with PRP-Part A
  • Fig. 49 Results obtained for individuals treated with PRP-Part B
  • Fig. 50 Results obtained for individuals treated with PRP-Part C
  • Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
  • Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2017 - 2028
  • Fig. 53 Reduction in the surface area of trophic ulcers
  • Fig. 54 Reduction in the surface area of trophic ulcers
  • Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2017 - 2028
  • Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
  • Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2017 - 2028
  • Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2017 - 2028
  • Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2017 - 2028
  • Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2017 - 2028
  • Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2017 - 2028
  • Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2017 - 2028
  • Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
  • Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
  • Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2017 - 2028 (USD Million)
  • Fig. 66 Platelet rich plasma (PRP) market for clinics, 2017 - 2028 (USD Million)
  • Fig. 67 Platelet rich plasma (PRP) market for others, 2017 - 2028 (USD Million)
  • Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
  • Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
  • Fig. 70 North America platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 71 U.S. platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 72 Canada platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 73 Europe platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 74 Germany platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 75 U.K. platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 76 Asia Pacific platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 77 Japan platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 78 China platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 79 Latin America platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 80 Brazil platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 81 Mexico platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 82 Latin America platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 83 South Africa platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 84 Strategy framework
  • Fig. 85 Market participation categorization
目次
Product Code: GVR-1-68038-869-5

Platelet Rich Plasma Market Growth & Trends

The global platelet rich plasma market size is estimated to reach USD 1.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2021 to 2028. Several research studies have been performed recently to assess the conditions and incidences of platelet rich plasma (PRP) usage across both nonoperative as well as operative settings. Recent research on these lines has concluded that the breadth and use of platelet rich plasma have increased significantly among Medicare beneficiaries, which is expected to drive the market.

Technological advancements in the development of novel and innovative platelet rich plasma products are expected to propel market growth. Market participants are developing advanced products to reinforce their market share and overcome current limitations. In February 2020, Florida-based EmCyte Corporation received FDA's 510(k) approval for its PurePRP Supraphysiologic Concentrating System, intended for producing platelet rich plasma from a small quantity of blood sample at Point-of-care (PoC) settings. This is an advanced autologous biologic concentrating system that can enable clinicians to improve their work.

The potential value of the market products lies in its ability to include high concentrations of platelet-derived fibrin and growth factors. Several research studies have demonstrated beneficial results with the usage of PRP in a wide range of clinical applications, such as orthopedics, sports medicine, cosmetic surgery, general surgery, neurosurgery, ophthalmic surgery, and others.

PRP injections are widely accepted in the orthopedic treatment, particularly focused towards joint pain relief and other bone defects, propelling the industry growth. It is also used to stimulate the formation of bone in spinal fusion surgeries. Additionally, integration of PRP in the management of COVID-19 patients, as an adjunct therapy is further expected to offer profitable business opportunities for the entities operational in this market.

Platelet Rich Plasma Market Report Highlights

  • The pure PRP segment accounted for the largest revenue share of over 52.0% in 2020. Compared to Leukocyte Rich Platelet rich plasma (LR-PRP), pure PRP can promote better repair of bone defects
  • LR-PRP can enhance bone regeneration by improving viability, proliferation, migration of cells in vitro, and osteogenesis and angiogenesis in vitro and in vivo
  • However, LR-PRP products can produce adverse or inferior effects, making pure type more suitable for bone regeneration
  • The combined use of P-PRP with B-tricalcium phosphate (B-TCP) is considered a simple, safe, and effective option in the treatment of bone defects. These factors are expected to boost the utilization of the same
  • Orthopedics dominated the market in 2020 accounting for a market share of more than 29.0%, while dermatology is expected to witness the fastest growth rate over the forecast period
  • A large number of orthopedic and general surgeries being performed in hospitals is contributing to the dominant share held by hospitals in the market
  • The growing competition in the global market can be attributed to the presence of several well-established companies as well as small and midsized entities
  • Established manufacturers are observing strategic product developments to ensure maximum product reach
  • In October 2019, a new design for packaging was introduced by Croma-Pharma GmbH for the company's ACP double syringe system. The unique appearance of Croma products has been integrated in this new design. Croma is an exclusive distributor of the Arthrex ACP double syringe system in 9 countries in Europe

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 GVR's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
    • 1.5.2 sports medicine market: segment revenue and growth analysis
    • 1.5.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
      • 1.5.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
      • 1.5.3.1.1 Non-Healing Ulcers
      • 1.5.3.1.1.1 Diabetic Ulcers
      • 1.5.3.1.1.2 Pressure Ulcers
      • 1.5.3.1.1.3 Pyoderma gangrenosum
      • 1.5.3.1.1.4 Venous ulcers
    • 1.5.4 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.8 Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook
  • 2.3 Market Summary, 2020 (USD Million)

Chapter 3 Platelet Rich Plasma (PRP) Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Parent Market Lineage
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers Analysis
      • 3.3.1.1 Rise in the incidence of orthopedic disorders and sports injuries
      • 3.3.1.2 Increasing number of cosmetic surgery procedures
      • 3.3.1.3 Extending medical applications of platelet rich plasma
      • 3.3.1.4 Increasing number of evidence-based studies for PRP-based wound healing
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 High costs associated with PRP products
    • 3.3.3 Market opportunity Analysis
      • 3.3.3.1 Increase in the breadth and use of PRP therapy across Medicare beneficiaries
  • 3.4 Penetration & Growth Prospect Mapping, by Application, 2020
  • 3.5 COVID-19 Impact Analysis: Platelet Rich Plasma (PRP) Market

Chapter 4 Business Environment Analysis

  • 4.1 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
  • 4.2 Porter's Five Forces Analysis

Chapter 5 Type Business Analysis

  • 5.1 Platelet Rich Plasma (PRP) Market: Type Movement Analysis
  • 5.2 Pure PRP
    • 5.2.1 Pure PRP market estimates and forecast, 2017 - 2028 (USD Million)
  • 5.3 Leukocyte Rich PRP
    • 5.3.1 Leukocyte rich PRP market estimates and forecast, 2017 - 2028 (USD Million)
  • 5.4 Others
    • 5.4.1 PRP market estimates and forecast for others, 2017 - 2028 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Platelet Rich Plasma (PRP) Market: Application Movement Analysis
  • 6.2 Orthopedics
    • 6.2.1 Platelet Rich Plasma (PRP) market estimates and forecast for Orthopedics, 2017 - 2028
  • 6.3 Sports Medicine
    • 6.3.1 Platelet Rich Plasma (PRP) market estimates and forecast for Sports medicine, 2017 - 2028
  • 6.4 Cosmetic Surgery
    • 6.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for cosmetic surgery, 2017 - 2028
  • 6.5 Dermatology
    • 6.5.1 coverage scneario: U.S. Centers for Medicare & Medicaid Services
    • 6.5.2 Platelet Rich Plasma (PRP) Market estimates and forecast for dermatology, 2017 - 2028
    • 6.5.3 Ulcer healing
      • 6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2017 - 2028
      • 6.5.3.2 Venous ulcers
      • 6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2017 - 2028
      • 6.5.3.3 Traumatic ulcers
      • 6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2017 - 2028
      • 6.5.3.4 Pyoderma gangrenosum ulcers
      • 6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2017 - 2028
      • 6.5.3.5 Diabetic ulcers
      • 6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2017 - 2028
      • 6.5.3.6 Trophic ulcers
      • 6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2017 - 2028
      • 6.5.3.7 Vasculitic ulcers
      • 6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2017 - 2028
    • 6.5.4 Others
      • 6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2017 - 2028
  • 6.6 Ophthalmic Surgery
    • 6.6.1 Platelet Rich Plasma (PRP) market estimates and forecast for Ophthalmic surgery, 2017 - 2028
  • 6.7 Neurosurgery
    • 6.7.1 Platelet Rich Plasma (PRP) market estimates and forecast for Neurosurgery, 2017 - 2028
  • 6.8 General Surgery
    • 6.8.1 Platelet Rich Plasma (PRP) market estimates and forecast for General surgery, 2017 - 2028
  • 6.9 Others
    • 6.9.1 Platelet Rich Plasma (PRP) market estimates and forecast for Others, 2017 - 2028

Chapter 7 End-Use Business Analysis

  • 7.1 Platelet Rich Plasma (PRP) Market: End-use Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Platelet Rich Plasma (PRP) market for hospitals, 2017 - 2028 (USD Million)
  • 7.3 Clinics
    • 7.3.1 Platelet Rich Plasma (PRP) market for clinics, 2017 - 2028 (USD Million)
  • 7.4 Others
    • 7.4.1 Platelet Rich Plasma (PRP) market for others, 2017 - 2028 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.2.2.2 U.S. Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.2.2.3 U.S. Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.2.3.2 Canada Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.2.3.3 Canada Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.3.2.2 Germany Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.3.2.3 Germany Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.3.3.2 U.K. Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.3.3.3 U.K. Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.4.2.2 Japan Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.4.2.3 Japan Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.4.3.2 China Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.4.3.3 China Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.5.2.2 Brazil Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.5.2.3 Brazil Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.5.3.2 Mexico Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.5.3.3 Mexico Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Middle East & Africa Platelet rich plasma (PRP) market estimates and forecast, 2017 - 2028 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Platelet rich plasma (PRP) market estimates and forecast, by type, 2017 - 2028 (USD Million)
      • 8.6.2.2 South Africa Platelet rich plasma (PRP) market estimates and forecast, by application, 2017 - 2028 (USD Million)
      • 8.6.2.3 South Africa Platelet rich plasma (PRP) market estimates and forecast, by end use, 2017 - 2028 (USD Million)

Chapter 9 Company Profile

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Johnson & Johnson
      • 9.3.1.1 Company overview
      • 9.3.1.2 DePuy Synthes
      • 9.3.1.2.1 Company overview
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product benchmarking
      • 9.3.1.5 Strategic initiatives
    • 9.3.2 Arthrex, Inc.
      • 9.3.2.1 Company overview
      • 9.3.2.2 FINANCIAL PERFORMANCE
      • 9.3.2.3 Product benchmarking
      • 9.3.2.4 Strategic initiatives
    • 9.3.3 EmCyte Corporation
      • 9.3.3.1 Company overview
      • 9.3.3.2 Product benchmarking
      • 9.3.3.3 Strategic initiatives
    • 9.3.4 DR. PRP AMERICA, LLC
      • 9.3.4.1 Company overview
      • 9.3.4.2 Product benchmarking
    • 9.3.5 Juventix
      • 9.3.5.1 Company overview
      • 9.3.5.2 FINANCIAL PERFORMANCE
      • 9.3.5.3 Product benchmarking
    • 9.3.6 Terumo Corporation
      • 9.3.6.1 Company overview
      • 9.3.6.2 TERUMO BCT, INC.
      • 9.3.6.2.1 Company overview
      • 9.3.6.3 Financial Performance
      • 9.3.6.4 Product benchmarking
      • 9.3.6.5 Strategic initiatives
    • 9.3.7 Zimmer Biomet
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product benchmarking
      • 9.3.7.4 Strategic initiatives
    • 9.3.8 Stryker
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 Apex Biologix
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Celling Biosciences
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.